|
Saturday
7
May
2011
11:00-12:30
Organiser:
Dorthe
Nielsen
(Odense,
Denmark)
Compliance
and
adherence
to
treatment
in
osteoporosis
is
often
low
in
clinical
settings.
Effective
disease
management
lies
in
the
hands
of
the
individual
patient,
who
must
take
responsibility
for
key
health
behaviours,
such
as
compliance
to
medicine,
physical
activity
use
of
tobacco,
alcohol
and
dietary
habits
related
to
bone
health.
This
working-group
is
designed
to
be
of
particular
interest
to
health
professionals
interested
in
challenges
related
to
issues
on
compliance
and
adherence
to
treatment.
The
session
will
include
oral
presentations
from
abstracts
selected
as
poster
presentations
for
the
main
meeting.
In
addition
to
the
talks,
there
will
be
short
discussions
of
some
of
the
issues
brought
up
and
why
they
are
significant
to
patients
as
well
as
professionals.
Attendance
at
this
session
is
free
of
charge
to
delegates
registered
for
the
main
congress.
|
Chairs:
|
|
Jon
Tobias
(Bristol,
United
Kingdom)
|
|
|
|
Dorthe
Nielsen
(Odense,
Denmark)
|
|
|
|
|
|
11:00
|
|
WELCOME
AND
PRESENTATION
OF
THE
WORKING
GROUP
|
|
|
|
D.
S.
Nielsen
1*
1Department
of
Endocrinology,
University
of
Southern
Denmark,
Odense,
Denmark
|
|
|
|
|
|
11:10
|
PP364-S
|
PREDICTORS
OF
ADHERENCE
TO
ORAL
BISPHOSPHONATE
THERAPY:
A
REGISTER-BASED
NATIONAL
OPEN
COHORT
STUDY
|
|
|
|
C.
A.
Hansen
1*,
B.
D.
Pedersen
2,
H.
Konradsen
3,
B.
Abrahamsen
4
1Dept
of
Medicine
C,
Gentofte
Hospital,
Hellerup,
2Research
Unit
of
Nursing,
Institute
of
Clinical
Research,
Faculty
of
Health
Sciences,
University
of
Southern
Denmark,
Odense,
3House
of
Research,
4Dept
of
Medicine
F,
Gentofte
Hospital,
Hellerup,
Denmark
|
|
|
|
|
|
11:25
|
PP395-M
|
ADHERENCE
TO
OSTEOPOROSIS
TREATMENT
IN
REAL
LIFE
SETTING
WITH
LONG
FOLLOW-UP.
|
|
|
|
L.
Pietrogrande
1*
on
behalf
of
GISMO
Lombardia,
C.
E.
Zaolino
1,
G.
Radaelli
2,
E.
Raimondo
1
1UO
Ortopedia
e
Traumatologia
AO
San
Paolo,
2Unit
of
Medical
Statistics,
San
Paolo
Hospital,
Università
Degli
Studi
Di
Milano,
Milano,
Italy
|
|
|
|
|
|
11:40
|
PP424-S
|
WHY
OLDER
WOMEN
FROM
PRIMARY
CARE
STOP
THEIR
BONE-PROTECTIVE
THERAPY
|
|
|
|
V.
C.
Gould
1*,
M.
Cuming
1,
J.
H.
Tobias
1,
E.
M.
Clark
1
1School
of
Clinical
Sciences,
University
of
Bristol,
Bristol,
United
Kingdom
|
|
|
|
|
|
11:55
|
PP362-M
|
AN
AUDIT
OF
THE
INDICATIONS
FOR
ZOLEDRONATE
AND
ITS
USE
IN
RENAL
IMPAIRMENT.
ARE
WE
STICKING
TO
THE
RULES?
|
|
|
|
B.
Hauser
1*,
M.
Suleman
1,
J.
Rintoul
1
1Rheumatology,
Royal
Cornwall
Hospital,
Truro,
United
Kingdom
|
|
|
|
|
|
12:10
|
PP392-M
|
FINAL
RESULTS
OF
18-MONTH
FOLLOW-UP
OF
GREEK
WOMEN
CONCLUDING
TERIPARATIDE
TREATMENT
IN
THE
EUROPEAN
FORSTEO
OBSERVATIONAL
STUDY
(EFOS).
|
|
|
|
K.
Aloumanis
1*,
V.
Drossinos
1,
A.
Polydorakis
1,
I.
Lasithiotakis
2,
I.
Notaras
3,
D.
Karras
4
1Medical,
Pharmaserve-Lilly
Saci,
Athens,
2Private
office,
Heraklion,
Crete,
3Private
office,
Volos,
4Veterans
Administration
Hospital,
Athens,
Greece
|
|
|
|
|
|
12:25
|
|
FINAL
REMARKS
|
|
|
|
|
|
12:30
|
|
CLOSE
OF
SESSION
|
|
|
|
|
|
